Boston Professional Events List


Biosimilar Market Access and Commercialization Strategies Summit


Date
Sep 18, 2017 - 07:00 AM - Sep 19, 05:00 PM
Organizer
exlevents
Location
TBD Boston, MA 01841,

Boston,
MA ,
US,
ZIP: 01841
Phone: +1 929 900 1853

Biosimilar Market Access and Commercialization Strategies Summit

Biosimilar Market Access and Commercialization Strategies Summit

The FDA’s approval of the first wave of biosimilars cleared the way for manufacturers to make lower-cost versions of expensive biologic drugs, saving patients money and improving access to important medications. There is a significant market opportunity ahead for biosimilar drugmakers; by 2020, leading biologic medicines worth more than $80 billion global annual sales will lose their patent protections, and biosimilars is the largest area for potential growth in the biotech sector. But with great rewards, there are also great risks that must be considered. In contrast to Europe, this is still an uncharted territory for the US market, and barriers to market access are not as low as they seem to be. From FDA approval to pricing and marketing strategies, there are risks and financial uncertainties. Therefore, the industry needs to know how to best address those challenges and optimize the biosimilar launch process.

Whether you are exploring your chances of tapping into the competitive biosimilars marketplace or are an expert in the field, the Biosimilar Market Access and Commercialization Strategies Summit will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests. Our talented faculty will address everything from navigating evolving regulations, analyzing optimal pricing models, accelerating market access strategies, and executing strategic decisions to mitigate risk and build for commercial success. In addition, designated lunches and networking breaks will enhance the exchange of knowledge and foster future business partnerships.

Top Five Reasons to Attend

  1. Explore factors to consider before developing biosimilars — improve your chances on the road to approval and commercial success
  2. Hear best practices and case studies for a successful biosimilar product strategy from its conception to execution
  3. Stay up to date with FDA guidances and other regulatory guidelines and join the debate on nonproprietary naming of biological and biosimilar products
  4. Navigate biosimilar policies, regulations and compliance issues under the new administration
  5. Network with leaders in the industry and get tips on how to manage payer and provider considerations for market entry, engage with patients, and stay competitive

Who Should Attend

This conference is designed for biotech professionals responsible for:

  • Biosimilars
  • Biologics/Biotechnology/Biogenerics
  • Biopharmaceuticals/Biotherapeutics
  • Market Access Commercialization
  • Marketing and Sales
  • Strategic/Corporate Planning
  • Pricing and Reimbursement
  • HEOR and Outcomes Research
  • Legal Affairs
  • Intellectual Property
  • Medical Affairs
  • Manufacturing/Bioprocesses
  • Clinical Affairs/Operations/Development
  • Regulatory Affairs
  • Medical Science Liaisons
  • R&D
  • Quality Control/Assurance
This event is also of interest to:
  • CROs/CMOs/CMDOs
  • Law Firms
  • API Manufacturers
  • Distributors
  • Consulting Companies
  • Market Access Providers
  • Licensing Services
  • Distribution and Logistics Services
  • Packaging and Labeling Companies
  • Preclinical/Nonclinical/Analytical Development Research Organizations
-----------------------------------------------------------------------------------------------------------------------------------
Please contact the event manager Marilyn below for the following:
 
- For Tickets/Registrations,
- Discounts for registering  5 or more participants.
- If you company requires a price quotation.
 
Event Manager Contact:


marilyn.b.turner(at)nyeventslist.com or Contact:  +1 929 900 1853
 
You can also contact us if you require a visa invitation letter, after ticket purchase.
We can also provide a certificate of completion for this event if required.
 
NO REFUNDS OR TRANSFER ALLOWED ON REGISTRATIONS
-----------------------------------------------------------------------------------------------------------------------------------
This Event Listing is Promoted by  New York Media Technologies LLC in association
with EXL Events Inc.

 
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------------------------------------------------------------------------
 


Agenda


The agenda for the Biosimilar Market Access and Commercialization Strategies Summit is currently under development. Case studies, panel discussions and general sessions may address the following areas and topics:

MARKET ACCESS/COMMERCIAL STRATEGY

  • Analyze the current status of biosimilar products in the US, Europe and rest of the world, and trends impacting market access in the US and globally
  • Hear best practices for the commercial strategy of a biosimilar from its planning to execution
  • Analyze the current biosimilars pipeline and likely market evolution
  • Learn how to market your brand and biosimilar product
  • Assess the application of biosimilars in combination products
  • Diversify your product and marketing strategy to compete in a highly competitive market
  • Review the right business and profit models to win
  • Understand which financial tactics will be most critical to success
  • Overcome challenges in physician and patient education

PRICING/REIMBURSEMENT

  • Discuss biosimilar pricing and rebate structures
  • Optimize pricing strategies to gain a better market position
  • Understand strategies for building alliances and how to collaborate with leaders in the industry to divide cost to increase production
  • Manage payer and provider considerations

REGULATORY/LEGAL/COMPLIANCE

  • Review the latest FDA interchangebility guidances and other regulatory guidelines
  • Evaluate the effects of Brexit and other key global regulatory considerations for biosimilars
  • Navigate biosimilar policies, regulations and compliance issues under the new administration
  • Assess FDA draft guideline on non-propriety naming of biological and biosimilar products
  • Ensure labeling compliance and assessing the impact of labeling

Keep watching this space for the latest updates on the agenda for ExL Events’ Biosimilar Market Access and Commercialization Strategies Summit.

Do you have a question or comment that you would like to be addressed at this event? Would you like to get involved as a speaker or discussion leader? Please contact Koray Ozkal, Conference Production Director, at [email protected].


Event Categories
Keywords: fun, access , administration , business , Clinical , conference , design , developing, development , Financial




Comments








Events Calendar

SunMonTueWedThuFriSat
27 28 29 30 31 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Tag Cloud

Newsletters

Subscribe
VIP Life Time Subscription to our Newsletters!
$399.99
$299.99